Amicus Therapeutics Inc (FOLD)

01:31 AM

Can Amicus Therapeutics Inc. stock maintain growth trajectoryWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com

01:31 AM

12:15 PM

How to escape a deep drawdown in Amicus Therapeutics Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com

12:15 PM

11:37 AM

Will Amicus Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Trung tâm Dự báo KTTV quốc gia

11:37 AM

04:50 AM

What RSI levels show for Amicus Therapeutics Inc. (AM6) stockPortfolio Return Report & Low Drawdown Trading Techniques - newser.com

04:50 AM

02:39 AM

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

02:39 AM

Oct 15, 2025

What earnings revisions data tells us about Amicus Therapeutics Inc.Market Trend Report & Reliable Intraday Trade Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Can volume confirm reversal in Amicus Therapeutics Inc.July 2025 Reactions & Real-Time Stock Movement Alerts - newser.com

Oct 15, 2025

Oct 14, 2025

Amicus Therapeutics Q2 2025 slides: Revenue grows 18% as rare disease portfolio expands - Investing.com Canada

Oct 14, 2025

Oct 14, 2025

Earnings call transcript: Amicus Therapeutics reports Q2 2025 earnings, stock dips - Investing.com

Oct 14, 2025

Oct 14, 2025

Amicus Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Oct 14, 2025

Oct 14, 2025

Why Amicus Therapeutics Inc. stock is a must watch in 2025July 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com

Oct 14, 2025

Oct 11, 2025

Amicus Therapeutics Inc Stock Analysis and ForecastFundamental Stock Analysis & Invest With Confidence - earlytimes.in

Oct 11, 2025

Oct 10, 2025

What Fibonacci levels say about Amicus Therapeutics Inc. reboundPortfolio Return Report & Consistent Profit Trade Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Will a bounce in Amicus Therapeutics Inc. offer an exitMarket Movers & Risk Controlled Stock Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Heatmap analysis for Amicus Therapeutics Inc. and competitorsEarnings Recap Summary & Entry Point Confirmation Signals - newser.com

Oct 10, 2025

Oct 10, 2025

What macro factors could drive Amicus Therapeutics Inc. (AM6) stock higherJuly 2025 Summary & Accurate Technical Buy Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Developing predictive dashboards with Amicus Therapeutics Inc. dataJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Amicus Therapeutics Inc. stock prediction for this weekMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com

Oct 10, 2025

Oct 09, 2025

Is Amicus Therapeutics Inc. (AM6) stock trading at attractive multiplesPortfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Real time scanner hits for Amicus Therapeutics Inc. explainedJuly 2025 Selloffs & Verified Entry Point Detection - newser.com

Oct 09, 2025

Oct 08, 2025

Amicus Therapeutics (NASDAQ:FOLD) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 08, 2025

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease - Nasdaq

Oct 08, 2025

Oct 08, 2025

Amicus Therapeutics (NASDAQ:FOLD) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat

Oct 08, 2025

Oct 08, 2025

Q3 EPS Forecast for Amicus Therapeutics Lifted by Analyst - MarketBeat

Oct 08, 2025

Oct 08, 2025

What Does Wall Street Think About Amicus Therapeutics (FOLD)? - MSN

Oct 08, 2025

Oct 07, 2025

All You Need to Know About Amicus Therapeutics (FOLD) Rating Upgrade to Strong Buy - sharewise.com

Oct 07, 2025

Oct 07, 2025

Is Amicus Therapeutics Inc AM6 a good long term investmentVWAP Trading Strategies & Consistent Triple Returns - earlytimes.in

Oct 07, 2025

Oct 07, 2025

How the Narrative Around Amicus Therapeutics Is Shifting Amid Legal and Pipeline Developments - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Zacks.com featured highlights include Amicus Therapeutics, Micron Technology and General Dynamics - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

14 Biotech Stocks with High Potential - Insider Monkey

Oct 07, 2025

Oct 07, 2025

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech Gem With 88% Potential Upside - DirectorsTalk Interviews

Oct 07, 2025

Oct 07, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Pass Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Oct 07, 2025

Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Fore - PharmiWeb.com

Oct 06, 2025

Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025

Oct 06, 2025

Bet on These 3 Stocks With Upgraded Broker Ratings for Solid Returns - TradingView

Oct 06, 2025

Oct 06, 2025

A Look at Amicus Therapeutics’s Valuation After Analyst Upgrade and Improved Outlook (FOLD) - Yahoo Finance

Oct 06, 2025